Article Details

Aqualung Therapeutics Plans A Phase 0 ARDS Trial for eNAMPT Monoclonal Antibody (Alt-100 ...

Retrieved on: 2021-06-15 19:18:45

Tags for this article:

Click the tags to see associated articles and topics

Aqualung Therapeutics Plans A Phase 0 ARDS Trial for eNAMPT Monoclonal Antibody (Alt-100 .... View article details on hiswai:

Excerpt

Aqualung Therapeutics Plans A Phase 0 ARDS Trial for eNAMPT Monoclonal Antibody (Alt-100 Mab) Following Type B FDA Meeting. By.

Article found on: www.digitaljournal.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up